Work and Social Adjustment Scale (WSAS)

Work and Social Adjustment Scale (WSAS) Overview

The Work and Social Adjustment Scale (WSAS) measures a distinct and clinically meaningful aspect of a person’s experience: the real-world impact of their difficulties, rather than symptom presence or severity. Individuals with similar symptom severity can differ substantially in how those symptoms affect their work, home management, leisure, and relationships. Common symptom measures, such as the PHQ-9 and GAD-7, often do not capture this dimension. Functional impairment is also an important clinical target in its own right. The WSAS can be used transdiagnostically across mental health, physical health, and other presentations.

The WSAS assesses five areas of functional impairment:

1. Work: ability to perform paid employment or its equivalent 
2. Home management: ability to manage household tasks such as shopping, cleaning, cooking, caregiving, and paying bills.
3. Social leisure: ability to participate in leisure activities with others.
4. Private leisure: ability to enjoy solitary leisure activities such as reading, gardening, and hobbies.
5. Close relationships: ability to form and maintain close relationships with others.

Each WSAS item begins with the phrase “Because of my difficulties…”, which ties the responses to the difficulties a person has identified. These could include a diagnosed mental or physical health condition, specific symptoms, a single concern, or multiple co-occurring difficulties. The WSAS does not ask the respondent to name or describe these difficulties; the wording simply prompts them to anchor their ratings to whatever they have in mind. This open framing makes the WSAS broadly applicable, as it can be used regardless of the cause of a person’s difficulties.

WSAS Example Item

WSAS and the Significance of Functional Impairment

Functional impairment is widely treated as a marker of clinical significance in mental health and broader clinical practice. Many DSM-5-TR disorders include a requirement that symptoms cause clinically significant distress or impairment across key areas of functioning before meeting the diagnostic threshold (American Psychiatric Association, 2022). This requirement highlights that often the experiential impact of a difficulty, not symptom presence alone, defines its clinical relevance. Different difficulties affect functioning in distinct ways and to different extents. For example, agoraphobia may primarily impact social engagement and movement outside the home, while a chronic physical condition may primarily limit work or daily activities. Functional impairment is also a key predictor of treatment-seeking, treatment retention, and relapse risk, and symptom remission alone does not always translate into functional recovery. 

Assessing functional impairment alongside symptom measures helps clinicians understand how a client’s difficulties affect their daily life, identify specific life domains to focus on for intervention, and track recovery beyond symptom checklists. The WSAS is well-suited to this purpose. It is brief, transdiagnostic, and directly assesses the social, occupational, and other important life areas referenced in the DSM functional-impairment criterion.

WSAS Clinical Applications

The WSAS’s brevity and direct mapping to specific life domains make it well-suited to a range of clinical and research applications:

• Brief index of overall functional impairment: The total score provides a single indicator of how severely a person’s identified difficulties affect their daily functioning and is useful at intake to establish a baseline.
• Progress monitoring across treatment: The short administration time supports frequent use and the evaluation of session-by-session change in functioning.
• Treatment target identification: Each of the five WSAS items corresponds to a distinct life domain, so elevated responses point directly to areas of intervention focus and can support shared goal-setting with the client.
• Pairing with symptom severity measures: Administering the WSAS alongside symptom-focused tools adds a functional dimension that those measures do not capture, giving clinicians a more complete picture of how a person’s difficulties affect them.

Work and Social Adjustment Scale (WSAS) Scoring

WSAS Severity Categories

• 0 to 9 (Subclinical): functional impairment is absent or minimal. The respondent may be experiencing distress, but day-to-day functioning is relatively preserved.
• 10 to 20 (Significant functional impairment): the respondent’s difficulties are meaningfully affecting day-to-day functioning, typically across one or more life domains.
• 21 to 40 (Moderately severe or worse): difficulties are substantially affecting day-to-day functioning, often across multiple life domains.

WSAS Percentile Context

WSAS Change Score Interpretation

• Significant reduction: equal to or greater than 5-point reduction in score.
• Significant increase: equal to or greater than 5-point increase in score.
• Minimal change: less than 5 points or no change in score.

WSAS Graphs

Work and Social Adjustment Scale (WSAS) Development

The WSAS was developed by Mundt et al. (2002) as a brief, self-report measure of patient-rated functional impairment. The original validation drew on data from 382 adults with depression and 197 adults with obsessive-compulsive disorder (OCD). Subsequent validation studies have extended this evidence base across multiple clinical populations and translated language versions (e.g., Lundqvist et al., 2024; Heissel et al., 2021; Shih et al., 2021; Tolchard, 2016).

Mundt et al. (2002) originally framed each item with the placeholder “Because of my [disorder]…”, suggesting that substitutions be implemented to suit clinical needs. Subsequent validation studies have used substitutions such as “my condition” (Zahra et al., 2014) and “the way I feel” (Thandi et al., 2017). The NovoPsych implementation uses “my difficulties,” chosen to keep the measure applicable across the widest range of clinical presentations and to reflect that people often face multiple co-occurring difficulties.

WSAS Factor Structure

The WSAS is unidimensional and scored as a single total. Multiple large samples (Pedersen et al., 2017; Heissel et al., 2021; Lundqvist et al., 2024) have confirmed this one-factor structure through confirmatory factor analysis. Items 3 (social leisure) and 5 (close relationships) show some overlap because both assess social aspects of functioning. However, this overlap is small and does not warrant treating them as a separate subscale.

WSAS Reliability

Internal consistency for the WSAS total score is strong and well-replicated. Mundt et al. (2002) reported Cronbach’s α ranging from .70 to .94 across multiple administrations in the development samples. Zahra et al. (2014) replicated this in the largest WSAS study to date (α = .82, N = 4,835 adults receiving routine UK primary-care psychological therapy primarily for anxiety or depression), and Lundqvist et al. (2024) reported α = .82 in 1,157 Norwegian community mental health patients.

Test-retest reliability evidence is limited but supportive. Mundt et al. (2002) reported r = .73 over two weeks in the OCD sample, Jansson-Fröjmark (2014) reported r = .99 over a one-week interval in 41 patients with chronic insomnia, and Vázquez Morejón et al. (2021) reported r = .78 over a two-to-three-week interval in a Spanish outpatient sample. No test-retest data have been reported for the largest UK primary care or psychiatric outpatient samples.

WSAS Validity

Convergent validity: WSAS scores correlate strongly with symptom severity. Mundt et al. (2002) reported strong correlations with the Hamilton Rating Scale for Depression (HRSD; r = .76) and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS; r = .61). Zahra et al. (2014) extended these findings in 4,835 adults receiving routine UK primary-care psychological therapy primarily for anxiety or depression, reporting correlations between WSAS scores and PHQ-9 (r = .58 to .74) and GAD-7 (r = .43 to .68) at intake and discharge.

Discriminant validity: Despite these correlations with symptom measures, the WSAS captures a distinct construct. Principal component analysis in the same UK primary-care sample (Zahra et al., 2014) showed that the WSAS loads on a factor separate from depression and anxiety symptoms, supporting its status as a measure of functional impairment rather than a proxy for symptom severity.

WSAS Sensitivity to Change

The WSAS is responsive to treatment-related change. Significant pre-post WSAS reductions have been demonstrated across diverse clinical populations and treatment contexts: depression and OCD (Mundt et al., 2002), phobic disorders (Mataix-Cols et al., 2005), routine UK primary-care psychological therapy (Zahra et al., 2014), Norwegian psychiatric outpatient treatment (Pedersen et al., 2017), and chronic insomnia (Jansson-Fröjmark, 2014). Effect sizes have ranged from moderate to large across these contexts. Jansson-Fröjmark (2014) further showed significant reductions only in the active treatment groups, not in the wait-list controls, supporting the conclusion that the observed WSAS changes reflect treatment effects rather than spontaneous improvement.

WSAS Sample Data

The reference sample used for percentile calculation on NovoPsych is the UK primary care baseline sample (Zahra et al., 2014; N = 4,835; mean 18.81, SD 9.17), the largest WSAS sample with reported distributional details. Other large clinical samples provide useful context for interpreting scores in specific populations: Lundqvist et al. (2024) reported diagnosis-specific averages (in a Norwegian psychiatric outpatient subsample of 1,051 with a single main diagnosis) ranging from 19.2 (primary ADHD) to 24.3 (primary depression), and Pedersen et al. (2017; N = 1,371 Norwegian outpatients in personality-disorder-focused treatment programs) reported averages of 23.9 for outpatients with personality disorders and 20.1 for those without.

No known general-population (non-help-seeking) WSAS reference sample has been published. The percentiles displayed in NovoPsych describe a respondent’s position relative to adults entering primary-care psychological therapy, not the general population.

WSAS Thresholds

Two descriptive severity band systems have been proposed in the WSAS literature.

1. Mundt et al. (2002): proposed bands of less than 10 (subclinical), 10 to 20 (significant impairment), and greater than 20 (moderately severe or worse), derived from WSAS scores across symptom-severity strata in the depression and OCD samples.
2. Mataix-Cols et al. (2005): proposed alternative bands of less than 15 (mild disability), 15 to 30 (moderate disability), and greater than 30 (severe disability), derived from phobic disorder severity strata.

NovoPsych applies the Mundt bands as the primary interpretive framework, reflecting their widespread clinical use and their role in the broader WSAS research literature. The Mataix-Cols bands have stronger external-validation evidence in Pedersen et al.’s (2017) head-to-head comparison: the Mundt bands fail to differentiate subclinical from significant-impairment groups on the Global Assessment of Functioning. A further limitation is that the Mundt top band captures the majority of routine clinical samples (53.6% of psychiatric outpatients in Lundqvist et al., 2024), indicating limited discrimination at the upper end.

Assess your patients with the Work and Social Adjustment Scale (WSAS) using a NovoPsych account

• For Psychologists & Mental Health Clinicians
• Send Assessments to Patient’s Phone
• Receive Comprehensive Reports
• Access Over 100 Validated Assessments
• Instant Psychometric Scoring
• Track Symptoms
• Inform Treatment